Charles A. Rowland Jr., VP, Chief Financial Officer at VIROPHARMA INC (VPHM), sold 35,000 shares at $18.55 ($650K) on 2011-03-14, disclosed to the SEC on 2011-03-15.
Open-market sale of $650k VPHM by VP, Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.55 | 10,000 | $186K | 28.5% |
| 2 | $18.58 | 25,000 | $464K | 71.5% |
| Total | $18.57 avg | 35,000 | $650K | 100% |
| Filing → |
| VKTX | SELL | 2023-05-18 | $1.0M | — | Filing → |
| GBIO | BUY | 2022-09-20 | $83K | — | Filing → |
| GBIO | BUY | 2022-09-19 | $552K | — | Filing → |